Concepedia

Héctor Terán-Navarro

HT

6

Publications

123

Citations

6

H-Index

2016

Active since

Affiliations

Instituto de Investigación Marqués de Valdecilla(Current)

Marqués de Valdecilla University Hospital

Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine

CIC biomaGUNE

Centro de Investigación Biomédica en Red de Enfermedades Respiratorias

Héctor Terán-Navarro is an author at Instituto de Investigación Marqués de Valdecilla specializing in immune function, immunoengineering, and precision vaccinology.

ORCID

Top concepts

Publications per year

2016–2022

6

Publications

6

Pregnancy Vaccination with Gold Glyco-Nanoparticles Carrying Listeria monocytogenes Peptides Protects against Listeriosis and Brain- and Cutaneous-Associated Morbidities

Ricardo Calderón-González, Héctor Terán-Navarro, Elisabet Frande‐Cabanes et al. · Nanomaterials · 2016 · 31 citations · Full text

, , +24

Gold glyconanoparticles coupled to listeriolysin O 91–99 peptide serve as adjuvant therapy against melanoma

Ricardo Calderón-González, Héctor Terán-Navarro, Marco Marradi et al. · Nanoscale · 2017 · 24 citations

Pre-clinical development of <i>Listeria</i>-based nanovaccines as immunotherapies for solid tumours: insights from melanoma

Héctor Terán-Navarro, Ricardo Calderón-González, David Salcines-Cuevas et al. · OncoImmunology · 2018 · 22 citations · Full text

Gold Glyconanoparticles Combined with 91–99 Peptide of the Bacterial Toxin, Listeriolysin O, Are Efficient Immunotherapies in Experimental Bladder Tumors

Héctor Terán-Navarro, Andrea Zeoli, David Salines-Cuevas et al. · Cancers · 2022 · 19 citations · Full text

GNP-GAPDH1-22 nanovaccines prevent neonatal listeriosis by blocking microglial apoptosis and bacterial dissemination

Ricardo Calderón-González, Elisabet Frande‐Cabanes, Héctor Terán-Navarro et al. · Oncotarget · 2017 · 17 citations · Full text

Rows per page

1–5 of 6